In healthy cells, Bax resides inactive in the cytosol because its COOH-terminal transmembrane region (TMB) is tucked into a hydrophobic pocket. During apoptosis, Bax undergoes a conformational change involving NH2-terminal exposure and translocates to mitochondria to release apoptogenic factors. How this process is regulated remains unknown. We show that the TMB of Bax is both necessary and sufficient for mitochondrial targeting. However, its availability for targeting depends on Pro168 located within the preceding loop region. Pro168 mutants of Bax lack apoptotic activity, cannot rescue the apoptosis-resistant phenotype of Bax/Bak double knockout cells, and are retained in the cytosol even in response to apoptotic stimuli. Moreover, the mutants have their NH2 termini exposed. We propose that Pro168 links the NH2 and the COOH terminus of Bax and is required for COOH-terminal release and mitochondrial targeting once this link is broken.
Conformational control of Bax localization and apoptotic activity by Pro168
The online version of this article contains supplemental material.
A. Schinzel's present address is Howard Hughes Medical Institute, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115.
Abbreviations used in this paper: ART, apoptosis-regulating targeting domain; IVTT, in vitro transcription/translation; MEF, mouse embryo fibroblast; MOM, mitochondrial outer membrane; PI, propidium iodide; PPIase, prolyl cis/trans isomerase; TMB, transmembrane region.
Anna Schinzel, Thomas Kaufmann, Martin Schuler, Jorge Martinalbo, David Grubb, Christoph Borner; Conformational control of Bax localization and apoptotic activity by Pro168 . J Cell Biol 29 March 2004; 164 (7): 1021–1032. doi: https://doi.org/10.1083/jcb.200309013
Download citation file:
Sign in
Client Account
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
Advertisement